LEADER 03287nam 2200613 450 001 9910822216103321 005 20230803221555.0 010 $a0-19-937888-6 010 $a0-19-937987-4 010 $a0-19-993781-8 035 $a(CKB)2550000001317745 035 $a(EBL)1712947 035 $a(SSID)ssj0001228586 035 $a(PQKBManifestationID)12422776 035 $a(PQKBTitleCode)TC0001228586 035 $a(PQKBWorkID)11178399 035 $a(PQKB)10060760 035 $a(StDuBDS)EDZ0001535462 035 $a(MiAaPQ)EBC1712947 035 $a(StDuBDS)EDZ0000862626 035 $a(Au-PeEL)EBL1712947 035 $a(CaPaEBR)ebr10884778 035 $a(CaONFJC)MIL619029 035 $a(OCoLC)881509748 035 $a(EXLCZ)992550000001317745 100 $a20140703h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTreatments for neurodevelopmental disorders $etargeting neurobiological mechanisms /$fedited by Randi Jenssen Hagerman and Robert L. Hendren 210 1$aOxford, England ;$aNew York :$cOxford University Press,$d2014. 210 4$dİ2014 215 $a1 online resource (401 p.) 300 $aDescription based upon print version of record. 311 $a0-19-993780-X 311 $a1-306-87778-4 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Treatment of Neurodevelopmental Disorders; Copyright; Contents; Foreword; Overview of Neurodevelopmental Processes and the Assessment of Patients with Neurodevelopmental Disorders; Autism: Neurobiological Mechanisms and Targeted Treatments; Targeted Treatments in Schizophrenia; Neurodevelopmental and Neurobiological Aspects of Major Depressive Disorder; Attention-Deficit Hyperactivity Disorder; Targeted Treatments in Rett Syndrome; Cardio-Facio-Cutaneous Syndrome and Other RASopathies; Targeted Treatments in Tuberous Sclerosis Complex (TSC) 327 $aTreatment of Fragile X Syndrome and Fragile X-associated DisordersAngelman Syndrome; Pharmacotherapy for Cognitive Enhancement in Down Syndrome; Targeted Treatments for Phenylketonuria; Muscular Dystrophies; Translating Treatments from the Laboratory to the Clinic; Index 330 $aThis cutting-edge book brings advances in genetics, neurobiology, and psychopharmacology to the clinic to enhance treatment for neurodevelopmental disorders. Significant progress has been made in identifying the neurobiological mechanisms of several disorders and targeted treatments are modifying the outcome of these disorders. However, the ability to utilize this knowledge has not been summarized in one place for the practicing clinician. This book will fill that gap by providing the theoretical underpinnings and the latest advances in targeted treatments. Several neurodevelopmental disorders 606 $aNervous system$xDiseases 615 0$aNervous system$xDiseases. 676 $a618.92/80475 702 $aJenssen Hagerman$b Randi 702 $aHendren$b Robert L. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910822216103321 996 $aTreatments for neurodevelopmental disorders$94014744 997 $aUNINA